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A defining feature of vertebrate immunity is the
acquisition of immunological memory, which confers
enhanced protection against pathogens by mecha-
nisms that are incompletely understood. Here, we
compared responses by virus-specific naive T cells
(TN) and central memory T cells (TCM) to viral antigen
challenge in lymph nodes (LNs). In steady-state LNs,
both T cell subsets localized in the deep T cell area
and interacted similarly with antigen-presenting
dendritic cells. However, upon entry of lymph-borne
virus, only TCM relocalized rapidly and efficiently
toward the outermost LN regions in the medullary,
interfollicular, and subcapsular areas where viral
infection was initially confined. This rapid peripheral-
ization was coordinated by a cascade of cytokines
and chemokines, particularly ligands for TCM-
expressed CXCR3. Consequently, in vivo recall re-
sponses to viral infection by CXCR3-deficient TCM
were markedly compromised, indicating that early
antigen detection afforded by intranodal chemokine
guidance of TCM is essential for efficient antiviral
memory.
INTRODUCTION
A hallmark of the vertebrate immune system is its capacity to
remember previous exposures to an infectious pathogen. This
unique feature, called ‘‘immunological memory,’’ is embodied
in long-lived, self-renewing lymphocytes that possess the ability
to respond more rapidly and vigorously to repeated exposure to
antigens (Ags) than naive lymphocytes. Understanding the
mechanisms by which immunological memory is exerted is
of pivotal importance for the design of effective vaccines
(Pulendran and Ahmed, 2006).
Numerous studies have demonstrated that memory T cells
have intrinsic qualities that allow more rapid responses uponCexposure to recall Ag, as compared to naive T cells (TN) (Sprent
and Surh, 2002). However, more recent in vivo studies suggest
that such cell-intrinsic differences may not be the only mecha-
nism to explain how memory T cells ‘‘remember’’ previous chal-
lenges. One case in point is effector memory T cells (TEM), which
are a subset of Ag-experienced T cells that are thought to arise
from effector T cells (TEff) and retain many properties of TEff
(Sallusto et al., 1999). Unlike TN, which recirculate through lymph
nodes (LNs) to search for their Ag, TEM reside in nonlymphoid
peripheral tissues (von Andrian and Mackay, 2000). The en-
hanced protection against reinfection afforded by TEM can be ex-
plained, at least in part, by their privileged access to tissues that
are particularly vulnerable to repeated invasions by pathogens
(Gebhardt et al., 2009; Irla et al., 2010; Masopust et al., 2001).
Whereas tissue-resident TEM provide the first line of defense
against reinfection, central memory T cells (TCM) participate in
the continuous immune surveillance of LNs, similar to TN. LNs
play a crucial role in the initiation, amplification, and reactivation
of immune responses to peripheral Ags (von Andrian and
Mempel, 2003). They achieve this function by monitoring the
lymph, which is generated in peripheral tissues by exudation of
aqueous fluid from capillaries and drained to local LNs via
afferent lymph vessels. This drainage system serves as an
essential conduit through which free Ag, migratory Ag-carrying
dendritic cells (DCs), and also intact microorganisms are trans-
ported to LNs for the initiation of adaptive immune responses.
While patrolling through lymphoid organs, resting TCM exert
limited immediate effector functions. However, upon Ag rechal-
lenge, TCM release interferon (IFN)g and divide rapidly, giving rise
to large numbers of TEff (Sallusto et al., 1999). Because invading
viruses can proliferate exponentially in a defenseless host, the
accelerated initiation of TEff activity afforded by TCM reactivation
is thought to provide a pivotal mechanism to curtail viral disease.
However, the mechanisms that render LN-resident TCM
responses more expedient than those by TN remains unclear.
How does T cell memory manifest itself at the single-cell level?
We sought to address these questions by using intravital
imaging strategies to compare the response kinetics of TN and
TCM in virally infected LNs. First, we asked whether there are
differences in the migratory or interactive behavior of TCM andell 150, 1249–1263, September 14, 2012 ª2012 Elsevier Inc. 1249
TN that might differentially affect their ability to contact Ag-
bearing DCs in the deep LN cortex. Second, we tested the
hypothesis that TCM may have preferred access to intranodal
recall Ag outside of the T cell area. This possibility was suggested
by recent findings that lymph-borne viruses are rapidly captured
by macrophages in the subcapsular sinus (SCS) and medulla of
LNs (Junt et al., 2007; Iannacone et al., 2010; Moseman et al.,
2012). We reasoned that, although macrophage capture of
viruses is important to prevent systemic dissemination, the
restricted distribution of early viral replication in the LNs may
pose a challenge for T cells to rapidly find their cognate Ag.
Our results demonstrate that the response kinetics of TCM and
TN to Ag-bearing DCs within the T cell area are surprisingly
similar. By contrast, TCM were more efficient at detecting and
responding to viral Ag within the first few hours after Ag appear-
ance in peripheral areas of LNs, which are poorly accessible to
TN. Our results elucidate how accelerated detection of Ag by
TCM is directed by a coordinated cascade of cytokines and
chemokines, particularly ligands for CXCR3. When directed
migration of TCM was disrupted, TCM reactivation was delayed
and viral clearance was compromised, indicating that antiviral
recall responses are critically dependent on this chemokine
pathway to enable viral Ag detection by CD8+ memory cells.
RESULTS
TN versus TCM Responses to Ag-Presenting DCs in Deep
LN Cortex
Upon peripheral infection, tissueDCs carry pathogen-derived Ag
into the deep T-cell-rich cortex of draining LNs (Alvarez et al.,
2008). CD8+ TN that access LNs via high endothelial venules
(HEV) become activated when they come upon a DC presenting
cognate Ag. This process involves three sequential phases that
are associated with distinct phenotypic and functional changes
in TN (Henrickson and von Andrian, 2007; Mempel et al., 2004;
Miller et al., 2004). Initially, TN engage in brief serial contacts
with multiple DCs and upregulate activation markers (phase 1).
After a few hours, they form prolonged stable conjugates that
persist for several hours and lead to secretion of effector cyto-
kines (phase 2). On the second day, T cells regain their mobility
and proliferate (phase 3). It has been unclear whether TCM
display similar dynamics in LNs.
To address this question, we compared the kinetics of CD8+
TCM and TN proliferation, effector differentiation, and interactive
behavior in popliteal LNs (popLNs) upon encounter of Ag-
presenting DCs (Figure S1A available online). Briefly, TN were
harvested from T cell receptor (TCR) transgenic P14 mice, which
recognize an immunodominant peptide from lymphocytic chorio-
meningitis virus (LCMV) glycoprotein (Pircher et al., 1989). Some
P14 TN were activated in vitro and were cultured forR9 days in
recombinant IL-15 to generate TCM-like cells as described (Man-
junath et al., 2001). Recipient micewere injected subcutaneously
(s.c.) into a footpad with Ag-pulsed DCs. The recipients were
injected intravenously (i.v.) 18 hr later with P14 TN or TCM, and
intranodal T cell activation and proliferation were monitored.
Upon encounter of Ag-pulsed DCs, CD69, a marker of early
T cell activation, was upregulated by TN and TCM with similar
kinetics (Figure 1A), and both subsets began to proliferate (Fig-1250 Cell 150, 1249–1263, September 14, 2012 ª2012 Elsevier Inc.ure 1B). There was also no difference between TN and TCM in
the rate of Ag-driven proliferation, which was estimated as the
proliferative response to Ag-pulsed DCs minus the Ag-indepen-
dent background proliferation of each subset (Figure 1C). Both
T cell populations secreted IFNg, but the response of TCM was
greater than that of TN (Figure 1D).
Migratory and Interactive Behavior of TN and TCM in
Deep LN Cortex
Having determined that the dynamics of TCM and TN responses
to Ag-pulsed DCs were similar in most aspects, we next asked
whether there were differences in migratory or interactive
behavior. The microanatomic distribution of homed TCM and TN
at steady state was similar, and >80% of cells localized to the
deep T cell area (Figures 1E, 1F, and S1C). Using multiphoton
intravital microscopy (MP-IVM) (Mempel et al., 2004), we
observed that both T cell populations displayed similarly high
motility in the deep cortex (Figure S1E).
Next, we compared the interaction dynamics of TCM and TN
with Ag-presenting DCs (Figure S1A) (Henrickson et al., 2008).
The duration of contacts with DCs was essentially the same for
TCM and TN during the first 10 hr after adoptive T cell transfer
(Figures 1G and S1D). DCs pulsed with a high peptide dose
(10 mM) supported the formation of stable contacts with both
T cell subsets within 2 to 4 hr after transfer (Figure 1G and Movie
S1), resulting in equivalent reduction in their migratory velocity
(Figure S1E). TCM and TN also interacted similarly with DCs
pulsed with 100 pM peptide concentration, which represented
the lowest pulsing dose that allowed DCs to induce full-fledged
proliferation of TCM and TN (Figure S1D). Neither TCM nor TN dis-
played prolonged interactions with DCs pulsed with 10 pM
peptide, which was below the threshold that triggered prolifera-
tion of either subset. We conclude that the intranodal motility and
interaction kinetics of TN and TCM with Ag-pulsed DCs are
roughly equivalent in character and magnitude. Moreover, the
interactive behavior of TCM depends upon the dose of cognate
Ag presented by DCs, which is consistent with previous findings
with TN (Henrickson et al., 2008).
Response Kinetics of TN and TCM upon LCMV Infection
in LNs
In light of these MP-IVM observations, we wondered whether
TCM are distinguishable from TN by other features that enable
rapid recall responses without requiring migratory DCs from
the periphery. This seemed appealing because viruses in the
interstitium can access local lymph vessels and accumulate in
draining LNs within minutes after deposition under the skin
(Junt et al., 2007). By contrast, peripheral DCs require many
hours to several days to reach LNs (Alvarez et al., 2008). Because
some viruses proliferate rapidly in host LNs, TCM could not
provide meaningful protection if their function depended upon
initial encounters with migratory DCs.
Indeed, when footpads of mice were injected s.c. with infec-
tious LCMV, approximately half of virus-specific TCM upregu-
lated CD69 within 8 hr, whereas CD69 expression on TN lagged
behind (Figure 1H). The onset of Ag-driven TCM proliferation was
also accelerated (Figures 1I and 1J). Thus, the early kinetics of
CD69 induction and proliferation were significantly faster for
Figure 1. Kinetics of TN and TCM Responses to Ag-Presenting DCs and LCMV Infection
(A–D) Kinetics of TN and TCM activation upon encounter of Ag-pulsedDCs in deep LN cortex. (A) Induction of CD69measured asmean fluorescence intensity (MFI;
left) and percent positive cells (right). (B) Proliferation, assessed by CFSE dilution (CFSEhi represent undivided cells). (C) Ag-driven proliferation, calculated as the
difference in percentage of divided P14 cells after encounter of DCs pulsed with cognate versus control Ag. (D) IFNg secretion.
(E) Micrographs showing the distribution of adoptively transferred TCM and TN in popLNs at steady state. Scale bar, 150 mm.
(F) Percentage of TCM and TN within indicated LN compartments at steady state (n = 3).
(G) MP-IVM analysis of TCM and TN interactions with DCs pulsed with 10 mM or 10 rM of peptide Ag.
(H–K) Kinetics of TN and TCM activation upon s.c. LCMV infection into a footpad. (H) Induction of CD69. (I) Proliferation, assessed by CFSE dilution (CFSE
hi
represent undivided cells). (J) Ag-driven proliferation, calculated as the difference in percentage of divided P14 cells after LCMV (cognate) versus VSV (control)
infection. (K) IFNg secretion.
**p < 0.01 and ***p < 0.001. Error bars represent mean ±SEM. See also Figure S1 and Movies S1 and S2.TCM than TN upon viral infection in LNs, whereas both subsets
responded equally when T cells homed to uninfected LNs that
contained Ag-pulsed DCs. By contrast, TCM mounted a more
vigorous IFNg response in both settings (Figures 1D and 1K).
Visualization of LCMV Replication in LNs
Given the faster early response kinetics of TCM versus TN upon
challenge with live virus, but not with Ag-pulsed DCs, we askedCwhether this disparity was due to differential accessibility of viral
Ag to the two T cell subsets. Thus, mice were infected in a
footpad with LCMV-enhanced green fluorescent protein (LCMV-
EGFP), which drives green fluorescent protein (GFP) expression
in infected cells (Emonet et al., 2009). At 8 hr after infection,
GFP expression was detected in the SCS and in the medulla,
but not in the T cell area of the popLN (Figures 2A and 2B). This
peripheral localizationofGFPreflectedLCMVreplicationbecauseell 150, 1249–1263, September 14, 2012 ª2012 Elsevier Inc. 1251
Figure 2. Differential Redistribution of TN versus TCM in Virally Infected LNs
(A–C) Micrographs of popLN sections 8 hr after footpad infection with LCMV-EGFP stained for leukocyte markers or viral Ags as indicated.
(D) Micrographs showing the distribution of adoptively transferred TCM and TN.
(E) Percentage of P14 TCM and TN within indicated LN compartments. n = 3–4.
(F) Micrographs showing the distribution of adoptively transferred P14 TCM and TN in popLNs 8 hr after footpad infection with VSV.
(G) Percentage of TCM and TN within indicated LN compartments. n = 3–4.
(H) Relative distance of TCM and TN from the centroid of the T cell area (calculated as the ratio of the median distances of TCM to the median distance of TN from
centroid in each section).
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staining of LCMV nucleoprotein gave an identical staining pattern
(Figure 2C). GFP+ viral host cells were predominantly macro-
phages, which included both the CD169hi subset in the SCS
and the CD169dim subset in the medulla (Figure 2B).
Differential Redistribution of TN versus TCM in Virally
Infected LNs
Having observed that early LCMV replication in LNs is restricted
to peripheral macrophage-rich compartments, we adoptively
transferred fluorescently tagged P14 TCM and TN to determine
their intranodal distribution before and after LCMV infection.
Whereas TCM and TN were both restricted to the deep T cell
area at steady state, 8 hr after LCMV infection, 90% of TCM
had relocalized to the medulla, interfollicular area (IFA), and
SCS (Figures 2D, 2E, and S1C). TN also peripheralized to some
extent, which is consistent with recent observations in
vaccinia-virus-infected LNs (Hickman et al., 2008). However,
compared to TCM, the kinetics and efficiency of TN redistribution
were substantially delayed and reduced, respectively (Figure 2E).
These findings are in line with the idea that TCM, by migrating
preferentially toward infected host cells outside of the T cell
area, may gain more rapid access to lymph-derived viral Ag
than TN.
TCM Interact with Virally Infected Cells after
Relocalization
Having established that TCM redistribute rapidly upon viral chal-
lenge, we asked whether TCM interact with infected APCs in their
environment. Indeed, upon infection with LCMV-EGFP, many
TCM that had migrated to the SCS contacted GFP
+ CD169+
SCS macrophages (Figure S2A). Interestingly, there was also
a striking redistribution of CD11c+ cells, which, in noninfected
LNs, display a fairly uniform distribution throughout the organ
(except for B follicles); by 8 hr after LCMV infection, CD11c+ cells
had formed dense clusters in the IFA and medulla (Figure S2B).
Most CD11cbright cells in these regions were GFP, yet many
formed clusters with TCM (Figure S2C). These cells likely repre-
sented DCs that cross-presented viral Ag acquired from infected
macrophages. By 24 hr after infection, the peripheral CD11c+
clusters had dissipated. Instead, CD11c staining was enhanced
in the deep T cell area (Figure S2B), suggesting that the DCs
migrated from the periphery to the deep cortex. Thus, following
virus-induced peripheralization, TCM appear poised to interact
with both macrophages and DCs capable of presenting viral Ag.
Role of TCR Specificity
To address whether TCR specificity is relevant in the process of
TCM peripheralization, we assessed the redistribution of LCMV-
specific TCM and TN upon infection with vesicular stomatitis virus
(VSV), which is not antigenic for P14 cells. Even in this setting,
TCM peripheralized rapidly, whereas TN remained mainly in the
deep cortex (Figures 2F–2H), indicating that TCM redistribute(I) Micrographs showing the distribution of adoptively transferred Ag-specific (P1
(J) Percentage of TCM in indicated LN compartments.
(K) CD45.2+ mice were adoptively transferred with 10,000–50,000 CD45.1+ P14 T
CD45.1+ cells in LN cross-sections within indicated compartments. Scale bars,
*p < 0.05, **p < 0.01, and ***p < 0.001. Error bars represent mean ±SEM. See al
Cwithout requiring TCR stimulation. However, Ag specificity also
played a role; in LCMV-infected LNs containing both specific
(P14) and nonspecific (OT-I) TCM, both subsets vacated the
T cell area, but many P14 TCM were tightly clustered in the outer-
most periphery, whereas nonspecific TCM congregated in less
superficial regions (Figures 2I and 2J). Moreover, MP-IVM
imaging of TCM in the superficial cortex of LCMV-EGFP-infected
LNs showed that the nonspecific TCMmigratedmore rapidly than
virus-specific TCM, which frequently arrested in vicinity to GFP
+
cells (Figures S2D–S2G and Movie S3). This suggests that
specific and nonspecific TCM may initially follow guidance cues
that do not attract TN, but subsequent encounter of cognate
Ag allows TCM to accumulate in immediate proximity to
infected APCs.
Redistribution of In-Vivo-Generated TCM
Although our in vitro method to generate TCM-like CD8
+ T cells
has been validated in multiple settings (Halin et al., 2005), it
was important to assess whether our observations with adop-
tively transferred ex-vivo-differentiated Ag-experienced T cells
reflected the behavior of endogenous TCM. To address this,
a small number of CD45.1+ P14 TN were injected into CD45.2
+
recipients that were then infected with LCMV. After 4 weeks,
the distribution of CD45.1+ memory cells in LNs was assessed
before and after rechallenge with LCMV. At steady state, the
largest fraction of CD45.1+ memory cells was found in the
T cell zone, whereas at 8 hr after rechallenge, the virus-specific
TCM had shifted into the IFA and medulla (Figures 2K and S2H–
S2J). Thus, in-vivo-generated bona fide TCM relocalize within
LNs as rapidly as ex-vivo-differentiated TCM-like cells.
CXCR3 Promotes TCM Redistribution in LNs
Next, we sought to identify the molecular guidance cues for
TCM peripheralization. Interstitial lymphocyte migration is chiefly
regulated by chemokines (Rot and von Andrian, 2004). Several
chemokine receptors are upregulated on TCM (Kaech et al.,
2002), including CXCR3, which recognizes two ligands in
C57BL/6 mice, CXCL9 and CXCL10. Indeed, both in-vivo- and
in-vitro-generated TCM were uniformly CXCR3
+, whereas TN
were CXCR3low/ (Figures 3A and S3A). Interestingly, expression
of CXCR3 on TCM in LCMV-draining LNs was 4.3-fold lower than
on TCM in contralateral LNs (Figure 3A), suggesting that the
receptor was downmodulated due to ligand stimulation. This
prompted us to compare the LCMV-induced relocalization of
P14 TCM and P14 CXCR3-KO TCM in LNs. Prior to infection,
both TCM subsets were concentrated in the deep T cell area.
However, 8 hr after infection, their distribution was strikingly
different; P14 CXCR3-KO TCM remained restricted to the deep
cortex, whereas P14 TCM accumulated in the medulla, SCS,
and IFA (Figures 3B and 3C). By contrast, there was no differ-
ence in the intranodal distribution of CXCR3-deficient TCM and
TN (Figure S3B), suggesting that CXCR3 is not involved in the4) and nonspecific (OT-I) TCM in popLNs 8 hr after LCMV infection.
N and were subsequently infected with LCMV s.c. into footpads. Percentage of
200 mm in (A) and (C), 100 mm in (B), and 150 mm in all other micrographs.
so Figure S2 and Movie S3.
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Figure 3. CXCR3 Promotes Viral-Infection-Induced TCM Redistribution in LNs
(A) CXCR3 expression on P14 TN and TCM in nondraining and draining popLNs 8 hr after footpad infection with LCMV.
(B) Micrographs showing the distribution of adoptively transferred P14 TCM and P14 CXCR3-KO TCM at rest or 8 hr after LCMV infection. Scale bars, 150 mm.
(C) Percentage of P14 TCM and P14 CXCR3-KO TCM in within indicated LN compartments. n = 3.
*p < 0.05 and **p < 0.01. Error bars represent mean ±SEM. See also Figure S3.subtle redistribution of TN, even though a fraction of TN stained
weakly with anti-CXCR3monoclonal antibody (mAb) (Figure 3A).
CXCR3 Ligands in LCMV-Infected LNs
Next, we sought to characterize the expression of CXCR3
ligands in LNs during a primary or secondary response against
LCMV. CXCL9 and CXCL10 messenger RNA (mRNA) levels
were measured in popLNs of four groups: (1) uninfected mice;
(2) mice infected in a footpad with LCMV for 7 hr (‘‘primary infec-
tion’’); (3) mice that had been infected with LCMV 25 days earlier
and had cleared the virus (‘‘no recall’’); and (4) mice infected with
LCMV 25 days earlier and rechallenged with LCMV for 7 hr
(‘‘secondary infection’’).
Interestingly, CXCL10 was strongly induced during both
primary and secondary infection, whereas CXCL9 was exclu-1254 Cell 150, 1249–1263, September 14, 2012 ª2012 Elsevier Inc.sively upregulated during secondary responses (Figure 4A).
Thus, we asked whether CXCL9 induction required Ag-specific
memory. To this end, we compared the expression of CXCL9
and CXCL10 in mice that had been infected with either LCMV
or VSV and 25 days later received a second infection with
LCMV. At 7 hr after rechallenge, both CXCL9 and CXCL10
mRNA levels were significantly higher in mice that had previously
encountered LCMV, whereas CXCL9was not detected in LCMV-
naive LNs regardless of their previous exposure to VSV (Fig-
ure 4B). We conclude that pre-existing antiviral memory is
needed to induce CXCL9, but not CXCL10.
Because CXCL9 and CXCL10 are both IFNg inducible (Farber,
1990; Luster et al., 1985), we tested how IFNg blockade affects
their expression during secondary LCMV infection (Figure 4C).
CXCL9 was nearly abrogated by anti-IFNg treatment, whereas
Figure 4. CXCR3 Ligands in LCMV-Infected LNs
(A) CXCL9 and CXCL10 mRNA expression measured by qPCR in popLN of the following: uninfected mice, mice infected with LCMV for 7 hr (‘‘primary’’), mice
infected with LCMV 25 days earlier (‘‘no recall’’), and mice infected with LCMV 25 days earlier and rechallenged with LCMV for 7 hr (‘‘secondary’’).
(B) CXCL9 and CXCL10 mRNA expression in popLNs of mice that were left uninfected, infected with LCMV or VSV only once, or reinfected with LCMV at day 25
after primary infection with VSV or LCMV.
(C) CXCL9 and CXCL10 mRNA expression in popLNs upon secondary LCMV infection, with or without anti-IFNg mAb treatment.
(D) CXCL9 andCXCL10mRNA expression in popLNs ofWT or IFNgR/mice adoptively transferredwith P14 TCM and subsequently infectedwith LCMV (7 hr). All
values were normalized to HPRT levels.
*p < 0.05, **p < 0.01, and ***p < 0.001 (one-way analysis of variance [ANOVA] Newman-Keuls multiple comparison test). Error bars represent mean ±SEM.CXCL10 was minimally affected, suggesting that IFNg secretion
by reactivated virus-specific TCM is necessary to induce the
former, but not the latter. Indeed, adoptive transfer of LCMV-
specific P14 TCM into naive wild-type (WT) hosts was sufficient
to induce CXCL9 expression after LCMV challenge (Figure 4D).
This CXCL9 response to LCMV was absent when P14 TCM
were transferred to IFNg-receptor-deficient (IFNgR/) recipi-
ents, whereas CXCL10 was still upregulated, albeit at a some-
what reduced level. Together, these results indicate that
CXCL9 depends strictly on IFNg produced by reactivated
memory T cells, whereas CXCL10 may be boosted by IFNg,
but a viral infection can induce CXCL10 independently of IFNg.CType I Interferon Initiates TCM Relocalization via
Induction of CXCL10
We surmised that CXCL10 was induced by an early innate signal
triggered by the incipient infection. A likely candidate was type I
interferon (IFN-I), which is rapidly produced in LNs undergoing
viral infections and can induce CXCR3 ligands (Mu¨ller et al.,
1994). Indeed, LCMV infection did not induce CXCL10 in animals
treated with a blocking mAb against the IFN-I receptor (IFNaR1;
Figure 5A). By contrast, CXCL10 levels were unaffected in
IFNgR/ LNs undergoing a primary LCMV infection, which is
consistent with the finding that anti-IFNg and IFNgR deficiency
have little impact on CXCL10 during secondary responsesell 150, 1249–1263, September 14, 2012 ª2012 Elsevier Inc. 1255
Figure 5. Type I Interferon Initiates TCM Relocalization via Induction of CXCL10
(A) CXCL10 mRNA expression in popLN of WT or IFNgR/ mice 7 hr after footpad LCMV infection, with or without anti-IFNaR1 mAb treatment.
(B) Micrographs showing the distribution of adoptively transferred nonspecific TCM in popLNs of CXCL10
/ mice (right) and of WT mice injected with isotype
control mAb (left) or anti-IFNaR1 mAb (middle). LNs were dissected 8 hr after footpad LCMV infection. Scale bars, 150 mm.
(C) Percentage of TCM in the T cell area (left). Ratio of TCM to TN in the T cell area, normalized by the total TCM to TN ratio in LN cross-section (middle). The ratio of the
median distance from centroid of the T cell area to TCM to the median distance from the centroid to TN (right).
***p < 0.001. Error bars represent mean ±SEM.(Figures 4C and 4D). Together, these results imply that the rapid
production of IFN-I upon viral infection induces CXCL10, which
then serves as a chemoattractant that precipitates the exodus
of CXCR3+ TCM from the T cell zone.
To test this idea, we compared the LCMV-induced redistribu-
tion of TCM versus TN inWT andCXCL10
/mice in the presence
and absence of anti-IFNaR1. We used nonspecific TCM here to
avoid potentially confounding effects of Ag-driven IFNg produc-
tion. Consistent with the concept that IFN-I is needed for
CXCL10 induction, TCM peripheralization upon LCMV infection
was markedly inhibited in anti-IFNaR1-treated mice (Figures
5B and 5C). Furthermore, in CXCL10/ mice, the distribution
of TCM and TN remained virtually identical, indicating that the
lack of TCM peripheralization after IFNaR1 blockade was due to
compromised CXCL10 induction.
IFNgProduction by TCM Induces CXCL9 in Stromal Cells,
Macrophages, and Monocytes
We next examined the role of CXCL9, which was only induced
during secondary responses (Figure 6A). The largest CXCL9+1256 Cell 150, 1249–1263, September 14, 2012 ª2012 Elsevier Inc.population was CD11b+Gr-1+ leukocytes, but CD169+CD11b+
Gr-1– macrophages, CD11c+ DCs, and CD45–gp38+ stromal
cells also expressed CXCL9 (Figures S4A and S4B). The same
pattern of CXCL9 expression was also seen in naive LCMV-
infected recipients of P14 TCM, but LCMV did not induce
CXCL9 in IFNgR/ recipients of P14 TCM or in WT recipients
of OT-I TCM or IFNg
/xP14 TCM (Figure 6B).
LCMV infection caused a substantial increase in CD11b+Gr-1+
myeloid cells within 8 hr after viral challenge. This effect was
apparent in naive animals (10-fold increase) and was further
exacerbated in previously immunized mice (30-fold increase;
Figure S4C). These newly recruited cells consisted of a minor
CD11bhiGr-1hi and a major CD11b+Gr-1int subset. Both subsets
were depleted when mice were injected i.v. with clodronate lipo-
somes (CLLs; Figure S4D), a procedure that depletes circulating
monocytes, but not LN macrophages (Tacke et al., 2006). This
suggests that peripheral LCMV infection is a potent stimulus
for the recruitment of circulating monocytes to LNs. Although
LCMV infection alone was sufficient for monocyte recruitment
to LNs, the newly recruited cells produced CXCL9 only when
Figure 6. Ag-Triggered IFNg Production by TCM Induces CXCL9 and Promotes TCM Peripheralization
(A) CXCL9 expression in popLN of uninfected mice, mice infected in a footpad with LCMV for 7 hr (‘‘primary’’), mice infected with LCMV 25 days earlier
(‘‘no recall’’), and mice infected with LCMV for 25 days and rechallenged with LCMV for 7 hr (‘‘secondary’’).
(B) CXCL9 expression measured by FACS in popLN of the following: control mice (no TCM), WT mice adoptively transferred with P14 TCM, nonspecific (OT-I) TCM
or P143 IFNg/ TCM, and IFNgR
/mice transferred with P14 TCM. Analysis was performed 8 hr after footpad LCMV infection. One-way ANOVANewman-Keuls
multiple comparison test was used.
(C) Micrograph showing the distribution of TCM and CXCL9 in LCMV-infected popLN (8 hr). Scale bar, 150 mm.
(D) Micrograph showing the distribution of TCM, CXCL9, and CD11c
+ DCs in the IFA and medulla of LCMV-infected popLN (8 hr). Scale bars, 100 mm.
(E) Micrographs showing the distribution of P14 TCM and TN in LCMV-infected popLNs of IFNgR
/ mice or IFNg/ mice. Scale bars, 150 mm.
(F) Percentage of P14 TCM within indicated LN compartments. n = 4.
**p < 0.01 and ***p < 0.001. Error bars represent mean ±SEM. See also Figures S4, S5, and S6.
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the LNs contained also endogenous or adoptively transferred
LCMV-specific TCM (data not shown), suggesting that TCM-
derived IFNg is required to induce CXCL9 in inflammatory mono-
cytes. Only the CD11b+CD169–Gr-1int subset (as well as 40%
of CD11b+CD169+Gr-1– resident macrophages) produced
CXCR9, but not the CD11bhiGr-1hi fraction, which also ex-
pressed CD169 (Figure S5).
CXCL9 Promotes TCM Peripheralization and Ag
Encounter
Fluorescence-activated cell sorting (FACS) analysis of permea-
bilized LN stromal cells revealed that 20% of CD45– cells con-
tained low levels of intracellular CXCL9 upon primary LCMV
infection. By contrast, upon secondary infection, >80% of
stromal cells were strongly positive (Figure S6A), and 15%
could be stained with anti-CXCL9 without permeabilization, indi-
cating that some stromal cells displayed CXCL9 on their surface,
providing a guidance cue for TCM peripheralization. Indeed,
immunostaining of frozen LN sections demonstrated that
CXCL9 was associated with the ERTR-7+ stromal network in
the IFA and the medulla and within some CD11b+ cells in the
same regions (Figures 6C, S6B, and S6C). Furthermore, there
was a strong correlation between intranodal TCM distribution
and CXCL9+ immunoreactivity.
The LN regions where CXCL9 was expressed contained not
only TCM, but also numerous CD11c
+ cells (Figure 6D), suggest-
ing that CXCL9 may promote encounters of viral Ag-presenting
cells with TCM, which may in turn produce IFNg to foster further
recruitment of TCM via CXCL9. Indeed, the fraction of TCM that
remained in the T cell area upon infection was significantly larger
in IFNgR/mice than inWT (Figures 6E and 6F), despite a partial
peripheralization of TCM, presumably in response to IFN-I-driven
CXCL10. Moreover, TCM peripheralization was also impaired in
CXCL9/ recipients (Figures 6F and S6D). Thus, although
CXCL10 alone can promote the initial formation of TCM contacts
with APCs in IFNgR/ hosts, TCM peripheralization remains
suboptimal in the absence of IFNg-induced CXCL9. Again, the
prerequisite source of IFNg was the TCM themselves because
adoptive transfer of IFNg-competent TCM into IFNg
/ hosts
was sufficient to induce TCM relocalization.
CXCR3 Deficiency Delays TCM Recall Responses
Finally, we asked how CXCR3 signaling affects the kinetics of
TCM activation upon LCMV rechallenge. We compared the acti-
vation kinetics of P14 TN and TCM to P14 CXCR3-KO TCM. When
P14 TCM and P14 CXCR3-KO TCM were activated with anti-CD3/
anti-CD28 in vitro, both subsets upregulated activation markers
and produced IFNg with similar kinetics, whereas TN responded
more slowly (Figures 7A and 7B), suggesting that CXCR3 defi-
ciency does not impair the cell-intrinsic capacity of TCM to
respond rapidly to rechallenge. However, when the cells were
adoptively transferred and analyzed in LNs upon challenge
with LCMV, the early activation of CXCR3-KO TCMwasmarkedly
delayed.
We next asked whether CXCR3 signaling affects the capacity
of TCM to clear cognate virus. To address this, LCMV titers in LNs
were determined by measuring mRNA levels of LCMV. To this
end, we adoptively transferred an equal number (5 3 105) P141258 Cell 150, 1249–1263, September 14, 2012 ª2012 Elsevier Inc.TN or TCM or P14 CXCR3-KO TCM into groups of mice and in-
fected the recipients’ footpads with LCMV. By 72 hr after infec-
tion, LCMV levels were significantly lower in draining LNs of mice
injected with P14 TCM as compared to animals injected with P14
CXCR3-KO TCM or P14 TN (Figure 7C). To confirm this result, we
measured intranodal LCMV titers as the infectivity of LN homog-
enates for cultured fibroblasts (Battegay et al., 1991). Consistent
with the quantitative PCR (qPCR) results, LN homogenates from
P14 TCM recipients contained significantly fewer focus-forming
units than recipients of P14 CXCR3-KO TCM (Figure 7D). Collec-
tively, these results indicate that the CXCR3 pathway acceler-
ates the encounter of viral Ag by TCM, which is critical to enhance
the efficiency of antiviral host defense during recall responses.
DISCUSSION
Memory T cells are composed of multiple subsets that differ in
the type of effector response they mediate and in their migratory
properties (Mora and von Andrian, 2006). Among those, TCM are
of particular interest because they have a greater capacity than
TEM to persist in vivo, and they are also more efficient at medi-
ating protective immunity because they have superior prolifera-
tive potential (Wherry et al., 2003). However, most previous
studies of TCM have evaluated their activity at the population
level and in settings in which Ag exposure was either systemic
or restricted to peripheral tissues (Gil-Cruz et al., 2012; Wherry
et al., 2003). Thus, although TCM are defined by their capacity
to recirculate through LNs, the precise function of TCM in those
organs and the mechanisms by which they differ from TN have
been unclear.
To fill this knowledge gap, we have compared how TCM and TN
respond in LNs to a model virus, LCMV, which requires a CTL
response for efficient clearance (Byrne and Oldstone, 1984).
Unexpectedly, our experiments revealed that both T cell subsets
responded similarly when they encountered the immunodomi-
nant peptide of LCMV on mature DCs within the T cell area.
The acquisition of activation markers, onset, and magnitude of
Ag-driven proliferation and the interaction dynamics with DCs
were all roughly equivalent. The only clear difference between
TN and TCM responses to Ag-pulsed DCs was a more vigorous
IFNg response by the latter. By contrast, when LNs were instead
infected with lymph-borne virus, activation and proliferation, as
well as IFNg production, occurred more rapidly in TCM than in TN.
The accelerated response of TCM to LCMV infection depended
upon a cascade of cytokines and chemokines, particularly
ligands for CXCR3, which selectively guided TCM migration
toward infected cells (Figure S7). Following LCMV challenge,
the initial signal for TCM redistribution was triggered as soon as
SCS and medullary macrophages became infected with the
lymph-borne virus because the infected cells rapidly released
IFN-I. This, in turn, triggered local production of the inflammatory
chemokine CXCL10, which diffused from the LN periphery
toward the deep cortex, establishing a concentration gradient
that TCM, but not TN, could follow. By tracking this chemoattrac-
tant cue, some TCM gained access to the LN periphery, where
they encountered viral Ag-presenting cells. TCR stimulation
then prompted IFN-g secretion by TCM, which provoked the
production of CXCL9 and further amplified the peripheralization
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Figure 7. CXCR3 Deficiency in TCM
Delays the Recall Response against LCMV
Infection
(A and B) P14 TN, P14 TCM, or P14 CXCR3-KO TCM
stimulated in vitro with anti-CD3/CD28 or har-
vested frompopLN 8 hr after footpad infectionwith
LCMV and analyzed for (A) CD69 induction and (B)
IFNg secretion.
(C) LCMV titers measured as LCMV gp mRNA in
popLN. Mice received footpad infections without
or with prior adoptive transfer of P14 TN, P14 TCM,
or P14 3 CXCR3-KO TCM, and titers were mea-
sured at 72 hr.
(D) LCMV titers measured by focus assay in
LCMV-infected popLNs of recipients of P14 TCM or
P14 CXCR3-KO TCM 72 hr after footpad infection.
*p < 0.05, **p < 0.01, and ***p < 0.001. Error bars
represent mean ±SEM. See also Figure S7.
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of TCM. The result was the rapid exodus of nearly all Ag-specific
TCM from the T cell area toward the SCS and medulla. CXCR3-
deficient TCM failed to peripheralize and could not provide
enhanced protection against LCMV rechallenge as compared
to TN, indicating that CXCR3 is a key determinant of TCM func-
tion, at least in LNs undergoing an acute LCMV infection.
These results confirm and expand the concept that the migra-
tory properties of TCM are a critical determinant of their protective
capacity. In addition to their sustained LN tropism, a feature that
they share with TN and that sets them apart from TEM (Sallusto
et al., 1999; Weninger et al., 2001), we show that TCM can
uniquely follow intranodal distress signals to migrate to the
most vulnerable regions of LNs where lymph-borne pathogens
are first encountered and that are poorly accessible to TN and
TEM. This capacity of TCM may be particularly relevant for intra-
cellular pathogens such as LCMV, which is highly proliferative
and elicits poor neutralizing antibody responses and, therefore,
requires rapid cell-mediated protection (Buchmeier et al.,
1980). Although it is unclear whether the CXCR3 dependence
of TCM is singularly relevant for LCMV in LNs or applies also to
other infectious settings, it seems likely that intranodal TCM
migration has a broad role in antiviral host protection. This
prediction appears inevitable if we consider the immunological,
microanatomical, and biophysical features that constrain or
promote viral dissemination in immunized hosts.
When the body’s surface barriers are breached by a previously
encountered pathogen, the ensuing recall response depends on
many factors, for example, the frequency and differentiation
status of host memory cells, the presence of neutralizing anti-
bodies, the pathogen’s host cell tropism, its expression of
ligands for pathogen-associated molecular pattern receptors,
proliferative capacity, and possibly even the size of the microbe.
Viruses that are not rapidly neutralized by humoral responses
may infect host cells at the site of entry, where theymust be elim-
inated by tissue-tropic TEM, TEff, or NK cells (Irla et al., 2010;
Masopust et al., 2001; Paust et al., 2010). Owing to their small
size, most virions can freely access the lymph drainage system
and are transported within minutes to downstream LNs (Junt
et al., 2007). Lymph-borne viruses whose host cell tropism is
restricted to peripheral tissues (e.g., influenza or herpes simplex
virus [HSV]) are captured by phagocytes without causing intra-
nodal infection (Gonzalez et al., 2010), whereas viruses with
broad host cell tropism (such as VSV or LCMV) or with specific
tropism for LN-resident cells may establish intranodal infections.
It seems likely that TCM are particularly critical for protection
against reinfection with those viruses (and other intracellular
pathogens [Chtanova et al., 2009]) that can become lymph borne
and invade LN-resident target cells.
Among all LN resident cells, macrophages within the SCS and
medulla are arguably the most exposed to infectious viruses
because they are constantly bathed in lymph fluid. All lymph-
borne viruses that have been tested to date are efficiently trap-
ped in LNs by SCS and/or medullary macrophages, which is
an important mechanism to prevent systemic pathogen dissem-
ination (Gonzalez et al., 2010; Junt et al., 2007). Thus, LNmacro-
phages often become the first site of intranodal viral replication.
Recent findings indicate that the continuous exposure of SCS
macrophages to surface-expressed lymphotoxin on follicular B1260 Cell 150, 1249–1263, September 14, 2012 ª2012 Elsevier Inc.cells provides a differentiation signal that renders this macro-
phage subset particularly susceptible to infection with VSV,
which triggers a protective IFN-I response (Moseman et al.,
2012). Unlike the SCS subset, medullary macrophages, which
are not in contact with follicular B cells, usually remain uninfected
by VSV. Interestingly, the present results indicate that medullary
macrophages are not resistant to LCMV infection but, together
with the SCS subset, represent the first target cells for intranodal
LCMV replication. The mechanism for this differential vulnera-
bility of medullary macrophages remains to be elucidated.
Irrespective of the location or mechanism of macrophage
invasion by LCMV, cytotoxic effector cells can only eliminate
the viral threat if they gain quick access to infected cells.
Because macrophages themselves are poorly migratory and
themacrophage-rich lymph conduits are remote from the central
T cell area, virus-specific T cells must have the means for direc-
tional migration toward viral Ag-presenting macrophages in the
outermost regions of the LN. Our results show that the infected
macrophages promote their own detection by sending out
molecular distress signals, CXCL9 and CXCL10, that attract
TCM. Of note, LCMV challenge not only provoked rapid peripher-
alization of TCM but also mobilized several other leukocyte
subsets, including myeloid cells and, to some extent, even TN.
For example, virally infected macrophages attract plasmacytoid
DCs (pDCs), which usually reside in the deep cortex and can
provide an additional source of IFN-I (Iannacone et al., 2010).
Because pDCs express CXCR3 (Cella et al., 1999), it seems
plausible that their recruitment is accomplished by the same
chemoattractant pathway that promotes TCM peripheralization.
Consistent with previous studies on T cell responses to
vaccinia virus or VSV (Hickman et al., 2008) or Toxoplasma gondii
(Chtanova et al., 2009), which also infect LN macrophages,
infection with LCMV induced a redistribution of TN toward the
LN periphery, albeit with lower efficiency and slower kinetics
than TCM. Neither the identity nor the source of the guidance
cue for intranodal TN redistribution are known, but it should be
noted that the inflammatory milieu in reactive LNs causes
CD8+ TN to acquire CCR5, a receptor for inflammation-induced
chemokines released by activated DCs (Castellino et al., 2006;
Hickman et al., 2011).Whatever the signal(s) for TN peripheraliza-
tion, it is possible that the same pathway or pathways also
contribute to TCM redistribution.
Besides altering the migratory properties of LN-resident
T cells, LCMV infection also caused a profound increase in
myeloid cells in LNs. Some of these cells could have accessed
LNs via afferent lymphatics; however, given the rapidity at which
myeloid cells appeared after LCMV exposure (<8 hr), they were
more likely recruited via HEVs from the blood. Two discrete
myeloid subsets were evident—a larger Gr-1+CD11b+ popula-
tion reflecting inflammatory monocytes and a minor subset
that was Gr-1hi CD11bhi and CD169+/low. A small fraction of
circulating monocytes/macrophages, as well pDCs, express
CXCR3 and could have been recruited to LCMV-infected LNs
by inflammation-induced CXCL10 (Janatpour et al., 2001;
Yoneyama et al., 2004). However, most circulating monocytes
do not express CXCR3. Their recruitment could have been
mediated by CCL2, a chemokine that is generated at sites of
inflammation and is transported via the lymph to HEVs in draining
LNs, where it then promotes homing of CCR2+ monocytes
(Palframan et al., 2001). Interestingly, the accumulation of
myeloid cells in LNs was significantly enhanced during sec-
ondary responses. Although neither TCM-derived IFNg nor host
cell expression of IFNgR was required for the recruitment of
myeloid cells, TCM-derived IFNg was essential to prompt the
newly recruited monocytes and other cells in the LN periphery
to produce CXCL9.
Together, these results suggest a scenario whereby TCM are
rapidly attracted toward infected macrophages by IFN-I-
induced CXCL10. Upon encounter of cognate Ag, TCM accel-
erate the recruitment of myeloid cells. Simultaneously, IFNg
release from reactivated TCM induces the production of CXCL9
from several different cellular sources, particularly from mono-
cytes. The peripheral confinement of CXCL9-producing cells
during secondary responses suggests that the newly recruited
monocytes, after entering the LN from HEV in the T cell area,
must first migrate toward the outer cortex and medulla. Here,
they encounter IFNg released by TCM, which induces the secre-
tion of CXCL9 into the interstitial space. CXCL9 then binds to the
cortical stroma cell network on which immobilized chemokines
provide haptotactic guidance cues that may facilitate the periph-
eralization of additional TCM toward the LN periphery. Although
CXCL9 was important for TCM migration to IFA, SCS, and
medulla, CXCL9 production in the latter region may not be abso-
lutely dependent upon IFNg because medullary accumulation of
TCM in IFNgR
/ hosts was only modestly affected.
At later stages of the infection, migratory DCs begin to arrive in
LNs carrying a secondwave of viral Ag from the periphery. These
cells must cross the SCS to migrate toward the T cell area
(Alvarez et al., 2008). During this process, DCs pass across the
macrophage-rich layer containing viral Ag-specific TCM that
had been previously attracted via CXCR3. Thus, the geographic
difference in T cell subset localization upon LCMV infection
provides an advantage to TCM versus TN to initiate communica-
tions with DCs. Because TN and TCM interacted similarly with Ag-
pulsed DCs in the deep cortex when their arrival in LNs was
synchronized, whatever kinetic advantage TCM may possess
over TN in obtaining information from DCs appears to result
from their preferential capacity to peripheralize. This allows
them to meet the incoming DCs halfway, whereas TN must await
the arrival of DCs in the deep cortex.
Our findings demonstrate how two chemokines sharing the
same receptor synergize to enable TCM function during distinct
phases of an antiviral recall response. The sequential appear-
ance of CXCL10 followed by CXCL9 is consistent with previous
observations in settings of viral infection and allotransplantation
(Hancock et al., 2001; Medoff et al., 2006) and can be explained
by the fact that the respective genes are differentially responsive
to cytokines, with CXCL9 being strictly dependent upon IFNg,
whereas CXCL10 is also inducible by IFN-I (Groom and Luster,
2011). The differential dependence of CXCL9 and CXCL10 on
a secondary T cell response to recall Ag was equally observed
in settings in which T cell memory had been induced endoge-
nously and in naive recipients of ex-vivo-differentiated TCM,
suggesting that adoptive transfer of IL-15-induced TCM is an
appropriate approach to study this process. It should be noted
that the C57BL/6 strain used here has a frame shift mutation inCthe gene for CXCL11, a third ligand for CXCR3 (Sierro et al.,
2007). Thus, the contribution of individual CXCR3 agonists to
TCM function could be even more complex in animals that
express functional CXCL11, including humans. In addition,
CXCR3 is implicated in other aspects of antiviral immunity,
including the regulation of effector and memory cell differentia-
tion (Hu et al., 2011; Kohlmeier et al., 2009; Kurachi et al.,
2011) and the recruitment of circulating TEFF to inflamed LNs
via HEV (Guarda et al., 2007). However, the latter mechanism
does not appear to contribute in the present setting because
WT and CXCR3-KO TCM home similarly to LCMV-infected LNs,
at least during the first 18 hr after infection (data not shown),
presumably because blood-borne TCM express classical LN
homing receptors that may be redundant with CXCR3. Thus,
the present findings highlight yet another critical role for
CXCR3 and its ligands and indicate that preferred access to
recall Ag, rather than differential interaction dynamics with
DCs, is a critical determinant of protective CD8 T cell memory
in LNs.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 mice were purchased from Charles River. P14 and OT-I mice, which
carry a transgenic TCR specific for LCMV glycoprotein (Pircher et al., 1989)
and ovalbumin (Hogquist et al., 1994), respectively, were purchased from
Taconic Farms. CXCR3-KO, IFNgR/, and IFNg/ mice were purchased
from Jackson Laboratory.CXCL9/mice were kindly provided by J.M. Farber
(NIAID) (Park et al., 2002). Both CXCL9/ andCXCL10/ (Dufour et al., 2002)
mice were backcrossed into C57BL/6 forR9 generations at MGH. Mice were
housed in a specific pathogen-free barrier facility. All experiments were in
accordance with NIH guidelines and were approved by the Institutional Animal
Committees of Harvard Medical School.
Viruses and Infections
LCMV Armstrong and VSV Indiana were propagated and purified as described
(Junt et al., 2007; von Herrath and Whitton, 2001). Mice were infected with
LCMV Armstrong (104 focus-forming units [FFU]) or VSV Indiana (104–105
plaque-forming unit [PFU]) by subcutaneous injection into the hind footpad.
LCMV titers were measured by quantitative PCR or focus assay as described
(Battegay et al., 1991). LCMV-EGFPwas kindly provided by J.C. de la Torre. All
infectious work was performed in designated BL2+ workspaces, in accor-
dance with institutional guidelines, and was approved by the Harvard Com-
mittee on Microbiological Safety.
Generation of Memory CD8 T Cells
CD45.2+ B6 mice were injected with 10,000–50,000 CD45.1+ P14 TN i.v.,
followed by infection with LCMV into footpads. After 25 days, CD45.1+
memory cells in the draining popLNs were detected by using an anti-CD45.1
antibody. Generation of memory-like CD8 T cells in vitro was performed as
described (Manjunath et al., 2001). Splenocytes from TCR transgenic mice
were incubated with cognate peptides (New England Peptide) at 37C
for 1 hr. Cells were washed and cultured for 2 days. Cells were split every
2 days, and 20 ng/ml of recombinant human IL-15 (R&D) was added into
media. After 9 days of culture, cells were tested for the expression of CD8,
CD44, CD69, CD62L, and CXCR3 by FACS.
Confocal Microscopy
PopLNs were processed for confocal microscopy as described (Junt et al.,
2007). LNs incubated overnight in phosphate-buffered l-lysine with 1% para-
formaldehyde/periodate (PLP). LNs were then cryoprotected by subsequent
incubations in 10%, 20%, and 30% sucrose in PBS at room temperature.
LNs were frozen in TBS tissue-freezing media (Triangle Biomedical Sciences)ell 150, 1249–1263, September 14, 2012 ª2012 Elsevier Inc. 1261
and were sectioned at 30 mm intervals. Images were acquired with an Olympus
Fluoview BX50WI inverted microscope and were analyzed by using Volocity
software (Improvision).
Statistical Analyses
Results are expressed as means ±SEM, and means were compared by using
a two-tailed t test, unless otherwise indicated. All statistical analyses were
performed in Prism Software.
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